MEGAN GORDON DON

Funding for cancer research in the FY17 Labor, Health & Human Services and Education Appropriations bill Funding for pancreatic cancer research in the FY17 Department of Defense Appropriations bill

Opposed Sections 756 and 898 of S.2943, the 2017 National Defense Authorization Act, which would prohibit funding for medical research at the Department of Defense (DoD) unless such research meets certain narrowly defined criteria related to military relevance

Concerns with the proposed Medicare Part B demonstration project

Funding for cancer research in the FY17 Labor, Health & Human Services and Education Appropriations bill Support for H.Res. 717 and S.Res. 459, which designate May as National Cancer Research Month Funding for pancreatic cancer research in the FY17 Department of Defense Appropriations bill

Funding for cancer research in the FY17 Labor, Health & Human Services and Education Appropriations bill Funding for pancreatic cancer research in the FY17 Department of Defense Appropriations bill

Supporting requiring that CMS develop quality measures that focus on the health outcomes of those with chronic diseases where cancer is considered a chronic condition

Supporting the January 2016 revisions to the Common Rule

Funding for cancer research in the FY16 Labor, Health & Human Services and Education Appropriations bill and in the Omnibus bill Support for the provisions in the 21st Century Cures Act (HR 6) that would increase funding for the National Institutes of Health

Recommending that CMS adopt an Alternative Payment System that would ensure the delivery of high-quality survivorship care to Medicare beneficiaries who are cancer survivors.

Funding for cancer research in the FY16 Labor, Health & Human Services and Education Appropriations bill Support for the provisions in the 21st Century Cures Act (HR 6) that would increase funding for the National Institutes of Health

Requesting that the NIH broaden its definition of "disease burden" to include diseases with very low five-year survival rates as part of the NIH-wide strategic plan.

Supporting the NIH's Precision Medicine cohort and requesting that the NIH use it as a tool in the development of early detection tools for our nation's deadliest cancers; Supporting the use of predictive biomarkers and asking the FDA to develop a strategy to accelerate the approval of targeted therapies for the deadliest cancers

Funding for cancer research in the FY16 Labor, Health & Human Services and Education Appropriations bill Opposition to Amendment #1482 to the FY2015 National Defense Authorization Act that prohibits funding for much of the medical research currently funded under the Department of Defense's Peer Reviewed Cancer Research Program Support for the provisions in the 21st Century Cures Act (HR 6) that would increase funding for the National Institutes of Health

Funding for cancer research in the FY16 Labor, Health & Human Services and Education Appropriations bill Funding for the Department of Defense's Peer Reviewed Cancer Research Program and requesting that pancreatic cancer once again be included as an eligible disease in the program

Supporting the FDA's framework for Laboratory Developed Tests (LDTs) and noting the importance of considering gene panels Commending NIH for advancing an IRB policy that encourages efficiency while protecting those that participate in research Supporting the American Cures Act Outlining priorities for the 21st Century Cures Act

Funding for cancer research in the FY 2015 Labor, Health & Human Services Appropriations Bill, the FY 2015 Department of Defense Appropriations Bill, and the Consolidated and Further Continuing Appropriations Act of 2015.

Requesting that the FDA include pancreatic cancer as one of the FDA-designated disease areas for patient-focused drug development meetings in FY 2016-2017. Supporting patient participation in FDA medical product reviews.

Funding for cancer research in the FY 2015 Labor, Health & Human Services Appropriations Bill

Funding for cancer research in the FY 2015 Labor, Health & Human Services Appropriations Bill

Opposing CMS' proposal to remove three classes of drugs from the "protected classes" status in Medicare Part D

Funding for cancer research in the FY 2015 Labor, Health & Human Services Appropriations Bill Support for the American Cures Act

Support of FDA proposed rule on Permanent Discontinuance or Interruption in Manufacturing of Certain Drug or Biological Products Support of change in SSA compassionate allowances listing on pancreatic ductal adenocarcinoma Support of CMS' steps to address various issues in the federally facilitated marketplace

Funding for cancer research in the FY 2014 Labor, Health & Human Services Appropriations Bill and Omnibus bill FDA user fees

Maintaining Orhpan Drug Tax Credit

Support of Orphan Drug tax credits

Funding for cancer research in the FY 2014 Labor, Health & Human Services Appropriations Bill

Support of the compassionate allowances program within the Social Security Administration FDA draft guidance on expedited programs for serious conditions Drug compounding and drug supply chain security

Funding for medical and cancer research in the FY 2014 Labor, Health, & Human Services Appropriations bill

Implementation of the Affordable Care Act: plans with multiple out-of-pocket limits do not have separate caps that exceed the total overall out-of-pocket limit established by the Act and urging guidance on implementation of the clinical trials provisions Comments to FDA on Structured Approach to Benefit-Risk Assessment in Drug Regulatory Decision-Making Protection of the drug supply chain systemSupport for amending the Federal Food, Drug, and Cosmetic Act to revise the pharmaceutical distribution supply chain (H.R. 1919) to promote traceability

Funding for cancer research in the FY 2013 Labor, Health, & Human Services Appropriations bill Funding for cancer research in the FY 2014 Labor, Health, & Human Services Appropriations bill

Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma Drug Shortages

The Pancreatic Cancer Research & Education Act (S. 362/ H.R. 733) The Recalcitrant Cancer Research Act Cancer patients needs in the essential health benefits package of the Affordable Care Act Draft guidance on laboratory-developed tests

The National Defense Authorization Act - Title X , Subtitle H, Section 1083 - Scientific framework for recalcitrant cancers

Funding for cancer research in the FY 2013 Labor, Health, & Human Services Appropriations bill

July 12, 2012 letter urging Congress to take a balanced approach to deficit reduction that does not include further cuts to nondefense discretionary (NDD) programs - signature of support.

The Recalcitrant Cancer Research Act (formerly the Pancreatic Cancer Research & Education Act) (S. 362/H.R. 733)

Funding for cancer research in the FY 2013 Labor, Health, & Human Services Appropriations bill Funding for the Peer-reviewed Cancer Research Program in the FY 2013 Department of Defense bill

Pancreatic Cancer Research & Education Act (S. 362/ H.R. 733)

The Pancreatic Cancer Research & Education Act (S. 362/ H.R. 733)

Funding for cancer research in the FY 2013 Labor, Health, & Human Services Appropriations bill Funding for the Peer-reviewed Cancer Research Program in the FY 2013 Department of Defense bill

The Pancreatic Cancer Research & Education Act (S. 362/ HR 733)

Funding for cancer research in the FY 2012 Labor, Health, & Human Services Appropriations bill

The Pancreatic Cancer Research & Education Act (S. 362/ HR 733)

Funding for cancer research in teh FY 2012 Labor, Health & Human Services Appropriations bill

The Pancreatic Cancer Research & Education Act (S. 362/H.R. 733)

Funding for cancer research in the FY 2012 Labor, Health & Human Services Appropriations bill.

Funding for cancer research in the FY 2011 & FY 2012 Labor, Health & Human Services Appropriations bill

The Pancreatic Cancer Research & Education Act (S.362/H.R. 733)

The Pancreatic Cancer Research & Education Act (S. 3320/H.R. 745) The 21st Century ALERT Act (S. 717)

Funding for cancer research in the FY 2011 Labor, Health & Human Services Appropriations bill.

The Pancreatic Cancer Research & Education Act (S. 3320/H.R. 745) The 21st Century ALERT Act (S.717)

Funding for cancer research in the FY 2011 Labor, Health & Human Services Appropriations bill

Funding for cancer research in the FY 2010 & FY 2011 Labor, Health & Human Services Appropriations bill

The Pancreatic Cancer Research & Education Act (S. 3320/H.R. 745) The 21st Century ALERT Act (S. 717)

The Pancreatic Cancer Research & Education Act (H.R. 745) The 21st Century ALERT Act (S. 717) Health Care Reform (H.R. 3590), Sections 6301 & 6302 on comparative effectiveness research and Section 2709 on clinical trials

Funding for cancer research in the FY 2010 & FY 2011 Labor, Health & Human Services Appropriations bill

Funding for cancer research in the FY 2010 Labor, Health & Human Services Appropriations bill

Medicare Physician Fee Schedule for CY 2010 Proposed rule related to changes in Medicare Advantage and the Medicare Part D prescription drug program

The Pancreatic Cancer Research & Education Act (H.R. 745) The 21st Century ALERT Act (S. 717) Health Care Reform (H.R. 3590), Sections 6301 & 6302 on comparative effectiveness research and Section 2709 on clincial trials Comprehensive Cancer Care Improvement Act (H.R. 1844/S.1773)

Funding for pancreatic cancer research in the FY 2010 Labor, Health & Human Services Appropriations bill

The Pancreatic Cancer Research & Education Act (H.R. 745) The 21st Century Cancer ALERT Act (S.717) Comprehensive Cancer Care Improvement Act (H.R. 1844) Health Care Reform (no specific bill)

Medicare Physician Fee Schedule for CY 2010

The Pancreatic Cancer Research & Education Act (H.R. 745) The 21st Century Cancer ALERT Act (S. 717)

Funding for pancreatic cancer research in the FY 2010 Labor, Health & Human Services Appropriations bill

American Recovery and Reinvestment Act of 2009 (H.R. 1), increasing funding for NIH and NCI Funding for pancreatic cancer research in the FY 2010 Labor, Health & Human Services Appropriations bill

The Pancreatic Cancer Research & Education Act (H.R. 745) The 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act (S.717)

Economic Stimulus Act of 2008 (H.R. 5140), increasing funding for NIH & NCI S.3230, L-HHS Appropriations Act for FY2009, Title II, all provisions relating to the National Cancer Institute

H.Res.1328/S.Res. 720, "Supporting the goals and ideals of National Pancreatic Cancer Awareness Month" H.R. 6791, "National Cancer Fund Act" H.R. 7045, "National Plan to Advance Pancreatic Cancer Act"

Research, Condition, and Disease Categorization (RCDC) system

S.3230, L-HHS Appropriations Act for FY2009, Title II, all provisions relating to the National Cancer Institute

H.Res. 1328, "Supporting the goals and ideals of National Pancreatic Cancer Awareness Month" H.R. 6791, "National Cancer Fund Act" H.R. 7045, "National Plan to Advance Pancreatic Cancer Act"

S.3230, L-HHS Appropriations Act for FY2009, Title II, all provisions relating to the National Cancer Institute H.R.2642, FY2008 Supplemental Funding, provisions relating to the National Cancer Institute

Medicare coverage for Positron Emission Tomography Medicare coverage for Clinical Trials

Research, Condition, and Disease Categorization (RCDC) system NIH Peer Review

Federal funding for pancreatic cancer research

H.R.3043, Consolidated Appropriations Act for Fiscal Year 2008, Title II all provisions relating to the National Cancer Institute H.R. 3043, L-HHS Appropriations Act for Fiscal Year 2008, Title II all provisions relating to the National Cancer Institute S.1710, L-HHS Appropriations Act for Fiscal Year 2008, Title II all provisions relating to the National Cancer Institute

H.R. 1078, The Comprehensive Cancer Care Improvement Act

Completion of the Review of the Drug Compendia Utilized in Medicare by the Center for Medicare & Medicaid Services (CMS) CMS Proposed Decision Memorandum on Medicare National Clinical Trial Policy H.R. 3061, Medicare Access to Critical Medications Act S. 1887, Medicare Access to Critical Medications Act Hospital Outpatient Prospective Payment System (OPPS), CY 2007 Payment Rates for Erthyropoiesis Stimulating Agents

H.J. Res. 20, Continuing Resolution for Fiscal Year 2007, Title I, all provisions relating to the National Cancer Institute H.R. 3043, L-HHS Appropriations Act for Fiscal Year 2008, Title II all provisions relating to the National Cancer Institute S. 1710, L-HHS Appropriations Act for Fiscal Year 2008, Title II, all provisions relating to the National Cancer Institute

H.Res.745, Establishing November 2007 as National Pancreatic Cancer Awareness Month

H.R. 5647, L-HHS Appropriations Act for Fiscal Year 2007, Title II all provisions relating to the National Cancer Institute S. 3708, L-HHS Appropriations Act for Fiscal Year 2007, Title II all provisions relating to the National Cancer Institute